Takeda Pharmaceutical annual dividends paid
2017
2018
2019
2020
2021
2022
2023
2024
2025
Takeda Pharmaceutical Dividends Paid Growth & History (TAK)
Takeda Pharmaceutical paid ¥302.50B in dividends during fiscal 2025.
View full Takeda Pharmaceutical company overviewTakeda Pharmaceutical annual dividends paid history
| Fiscal year | Period ended | Dividends paid | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-03-31 | ¥302.50B | ¥15.31B | +5.33% |
| 2024 | 2024-03-31 | ¥287.19B | ¥7.77B | +2.78% |
| 2023 | 2023-03-31 | ¥279.42B | −¥4.25B | −1.50% |
| 2022 | 2022-03-31 | ¥283.67B | ¥308.0M | +0.11% |
| 2021 | 2021-03-31 | ¥283.36B | ¥775.0M | +0.27% |
| 2020 | 2020-03-31 | ¥282.58B | ¥139.63B | +97.68% |
| 2019 | 2019-03-31 | ¥142.95B | ¥1.06B | +0.75% |
| 2018 | 2018-03-31 | ¥141.89B | ¥205.0M | +0.14% |
| 2017 | 2017-03-31 | ¥141.69B | — | — |
Takeda Pharmaceutical quarterly dividends paid
Q1.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q3.20
Q1.21
Q3.21
Q1.22
Q3.22
Q1.23
Q3.23
Q1.24
Q3.24
Q1.25
Q3.25
| Fiscal quarter | Period ended | Dividends paid | Change | YoY change |
|---|---|---|---|---|
| Q3 2025 | 2024-12-31 | ¥155.89B | ¥7.86B | +5.31% |
| Q1 2025 | 2024-06-30 | ¥148.04B | ¥7.57B | +5.39% |
| Q3 2024 | 2023-12-31 | ¥148.04B | ¥7.56B | +5.38% |
| Q1 2024 | 2023-06-30 | ¥140.47B | ¥110.0M | +0.08% |
| Q3 2023 | 2022-12-31 | ¥140.47B | −¥1.91B | −1.34% |
| Q1 2023 | 2022-06-30 | ¥140.37B | −¥1.49B | −1.05% |
| Q3 2022 | 2021-12-31 | ¥142.39B | ¥527.0M | +0.37% |
| Q1 2022 | 2021-06-30 | ¥141.86B | ¥1.0M | +0.00% |
| Q3 2021 | 2020-12-31 | ¥141.86B | ¥0 | 0.00% |
| Q1 2021 | 2020-06-30 | ¥141.86B | ¥0 | 0.00% |
| Q3 2020 | 2019-12-31 | ¥141.86B | ¥3.0M | +0.00% |
| Q1 2020 | 2019-06-30 | ¥141.86B | ¥1.02B | +0.73% |
| Q4 2019 | 2019-03-31 | ¥140.84B | ¥69.33B | +96.95% |
| Q3 2019 | 2018-12-31 | ¥141.86B | ¥70.35B | +98.38% |
| Q2 2019 | 2018-09-30 | ¥71.51B | ¥344.0M | +0.48% |
| Q1 2019 | 2018-06-30 | ¥140.84B | ¥69.33B | +96.95% |
| Q4 2018 | 2018-03-31 | ¥71.51B | ¥374.0M | +0.53% |
| Q3 2018 | 2017-12-31 | ¥71.51B | ¥344.0M | +0.48% |
| Q2 2018 | 2017-09-30 | ¥71.17B | ¥43.0M | +0.06% |
| Q1 2018 | 2017-06-30 | ¥71.51B | ¥374.0M | +0.53% |
| Q4 2017 | 2017-03-31 | ¥71.13B | ¥21.0M | +0.03% |
| Q3 2017 | 2016-12-31 | ¥71.17B | — | — |
| Q2 2017 | 2016-09-30 | ¥71.12B | — | — |
| Q1 2017 | 2016-06-30 | ¥71.13B | — | — |
| Q1 2016 | 2016-03-31 | ¥71.11B | — | — |
Takeda Pharmaceutical dividends paid trends
Over the last five fiscal years, Takeda Pharmaceutical's dividends paid increased from ¥282.58B to ¥302.50B, a change of ¥19.92B. The latest reported quarter, Q3 2025, shows ¥155.89B.
About the metric
What dividends paid mean
Dividends paid are cash distributions made to shareholders. The history shows the company’s aggregate cash outflow for dividends, not the dividend per share, dividend yield, or the date an investor receives a payment.
Calculation and source
Reported cash dividends paid
TickerStat standardizes cash dividends paid to common or ordinary shareholders from official cash-flow filings. Reported zero-dividend periods remain zero and are not treated as missing data. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Takeda Pharmaceutical source filings ↗